Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devlin

Showing results (631-640 of 803) with videos related to

Pageof 81
Sort By:
Urologic Oncology|December 26, 2017
Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancerMartin T King, Ming-Hui Chen, Brian J Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Journal of Physical Activity & Health|July 9, 2021
Priorities and Indicators for Economic Evaluation of Built Environment Interventions to Promote Physical ActivityAngie L Cradock, David Buchner, Hatidza Zaganjor, et al.
Neuro-Oncology Advances|May 16, 2022
Salvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysisKyle C Wu, Jonathan M Cantalino, Edward C Dee, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
Blood|March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myelomaNikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
The Oncologist|October 9, 2015
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell TransplantationLee W Jones, Sean M Devlin, Molly A Maloy, et al.
Leukemia & Lymphoma|May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenanceHani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.
The Journal of Biological Chemistry|December 11, 2014
Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2Melissa L Fishel, Xue Wu, Cecilia M Devlin, et al.
Pageof 81

Showing results (631-640 of 803) with videos related to

Sort By:
Pageof 81
Urologic Oncology|December 26, 2017
Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancerMartin T King, Ming-Hui Chen, Brian J Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Journal of Physical Activity & Health|July 9, 2021
Priorities and Indicators for Economic Evaluation of Built Environment Interventions to Promote Physical ActivityAngie L Cradock, David Buchner, Hatidza Zaganjor, et al.
Neuro-Oncology Advances|May 16, 2022
Salvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysisKyle C Wu, Jonathan M Cantalino, Edward C Dee, et al.
Leukemia & Lymphoma|January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantationGunjan L Shah, Heather Landau, Dory Londono, et al.
Blood|March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myelomaNikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
The Oncologist|October 9, 2015
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell TransplantationLee W Jones, Sean M Devlin, Molly A Maloy, et al.
Leukemia & Lymphoma|May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenanceHani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.
The Journal of Biological Chemistry|December 11, 2014
Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2Melissa L Fishel, Xue Wu, Cecilia M Devlin, et al.
Pageof 81